Tyagarajan Seshu 4
4 · Candel Therapeutics, Inc. · Filed Nov 30, 2022
Insider Transaction Report
Form 4
Tyagarajan Seshu
Chief Technology Officer
Transactions
- Award
Common Stock
2022-11-28+73,684→ 73,684 total
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on November 28, 2023, and the remaining 50% on November 28, 2024, in each case subject to the Reporting Person's continued service on such vesting date.